Status:
RECRUITING
Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Esophageal Varices
Portal Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Endoscopic esophageal variceal ligation combined with gastric variceal embolization using tissue glue is currently the first-choice method for preventing rebleeding in patients with cirrhosis and port...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of portal hypertension;
- Underwent imaging and endoscopic examination or treatment within one week after admission;
- Endoscopy revealed the presence of esophageal and/or gastric varices.
Exclusion
- CT image slice thickness does not meet the requirements or there are artifacts;
- Endoscopy shows no presence of esophageal and/or gastric varices;
- Presence of severe life-threatening diseases of the circulatory, hematological, or respiratory systems;
- Lack of important historical medical information or other relevant data.
Key Trial Info
Start Date :
March 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2032
Estimated Enrollment :
1450 Patients enrolled
Trial Details
Trial ID
NCT06970509
Start Date
March 1 2025
End Date
December 1 2032
Last Update
May 14 2025
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Southern Medical University Nanfang Hospital
Guangzhou, Guangdong, China
2
The Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
3
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
4
People's Liberation Army Northern Theater General Hospital
Shenyang, Liaoning, China